Xinle Wu

Xinle Wu

Company: Sciwind Biosciences

Job title: Chief Scientific Officer & Head of Research


Panel Discussion: Navigating the Evolving NASH Landscape to Apprehend the Future of Combination Therapies & Optimize Treatment 2:30 pm

Deliberating the best approaches to position GLP-1s for different indications, mono therapy, and combination therapy How are we maximizing the use of injectables and oral medicines? Uniting towards a shared goal to advances towards efficacious NASH treatments through collaborative effortsRead more

day: Day 1 Seminar B Post-Lunch Tracks

Disentangling Cutting-Edge Insights in Combination Therapy for Obesity & NASH Treatment 12:30 pm

Combination of GLP-1 and other mechanism has potential to lead to better therapeutic profile GIP, Amylin and GDF15 demonstrated synergy with GLP-1R agonist Unravelling novel considerations for designing combination studiesRead more

day: Day 1 Seminar B Pre-Lunch Tracks

A Hanson Wade Group Company

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.